Blog Archives for Government - Surplus

Sunday, September 20, 2015

Lutetium-177 PSMA radionuclide treatment (Lu-PSMA

Lutetium-177 PSMA radionuclide treatment (Lu-PSMA) is a treatment that is new sophisticated prostate cancers. Lu-PSMA is really a molecule that is radioactive especially attaches to tissue with a high amounts of PSMA on top associated with the cells. This enables the radioactivity becoming provided primarily towards the prostate cancer tissues wherever obtained distribute, while sparing more regular tissue. Previous lightweight scientific studies of Lu-PSMA demonstrated activity that is promising people with advanced prostate cancer tumors.
This study that is randomised examine through a types of radiation treatment also known as cabazitaxel, that is the typical treatment for higher level prostate cancer tumors whenever other treatment options posses stopped operating. Half the participants will receive Lu-PSMA and 1 / 2 shall get cabazitaxel. This study will offer further information about the danger and great things about Lu-PSMA weighed against cabazitaxel in men with prostate cancer. We plan to enrol 200 individuals within the scholarly learn in Australia.

TheraP is a collaboration between ANZUP cancer tumors studies team and also the Prostate cancer tumors first step toward Australia (PCFA) with support through the Australian Nuclear Science and Technology organization (ANSTO), Endocyte, It’s a Bloke Thing, Movember and CAN4CANCER.

Posted in Uncategorized